Avanos Medical Inc. (AVNS)
NYSE: AVNS
· Real-Time Price · USD
11.20
0.24 (2.19%)
At close: Aug 15, 2025, 3:59 PM
11.22
0.22%
After-hours: Aug 15, 2025, 06:00 PM EDT
Avanos Medical Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 90.3M | 97M | 107.7M | 89M | 92.2M | 75.8M | 87.7M | 107.1M | 81.8M | 95.7M | 127.7M | 117M | 106.5M | 104.3M | 118.5M | 97.8M | 99.9M | 100.1M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 25.7M | 25.4M | 23.2M | 25.8M | 16.7M | 19.1M | 19.3M | 18.4M | 18.5M | 18.6M | 17.6M | 16.1M | 16.5M | 15.9M | 16.5M | 11.1M | 11M | 11.3M |
Receivables | 110.2M | 104.8M | 132.8M | 131.9M | 123M | 131.3M | 142.8M | 145.2M | 152.3M | 142.7M | 167.9M | 146.2M | 145.4M | 161.6M | 118.2M | 129.1M | 165.1M | 164.3M |
Inventory | 142.7M | 138.1M | 138.8M | 161.9M | 163.9M | 165.6M | 163.2M | 156.6M | 148.3M | 200M | 190.3M | 193.6M | 169M | 157.6M | 150.3M | 158.4M | 159.7M | 165.2M |
Other Current Assets | 12.8M | 12.5M | 14.1M | 89.8M | 95M | 95.1M | 93.3M | 115.7M | 124.5M | 15.4M | 13.9M | 13.2M | 16.2M | 15.7M | 13M | n/a | n/a | n/a |
Total Current Assets | 356M | 352.4M | 393.4M | 472.6M | 474.1M | 467.8M | 487M | 524.6M | 506.9M | 453.8M | 499.8M | 470M | 437.1M | 439.2M | 418.6M | 405M | 443.5M | 447.9M |
Property-Plant & Equipment | 145.4M | 141.9M | 144.8M | 136M | 140.1M | 140.4M | 144M | 143.9M | 151.7M | 191.8M | 194.5M | 195.9M | 198.2M | 203M | 206.7M | 211.1M | 214.8M | 218.5M |
Goodwill & Intangibles | 486.6M | 563.1M | 567.9M | 1.02B | 1.02B | 1.03B | 1.04B | 1.03B | 985.2M | 1.07B | 1.07B | 1.08B | 1.09B | 1.1B | 942.8M | 947.1M | 952.1M | 955.7M |
Total Long-Term Assets | 683M | 755.4M | 760.8M | 1.18B | 1.18B | 1.19B | 1.21B | 1.2B | 1.16B | 1.28B | 1.29B | 1.31B | 1.32B | 1.33B | 1.18B | 1.19B | 1.24B | 1.2B |
Total Assets | 1.04B | 1.11B | 1.15B | 1.66B | 1.66B | 1.66B | 1.69B | 1.72B | 1.67B | 1.73B | 1.79B | 1.78B | 1.75B | 1.77B | 1.59B | 1.6B | 1.68B | 1.65B |
Account Payables | 48.8M | 46M | 54.3M | 54.2M | 51.4M | 57M | 56.3M | 52.1M | 65.4M | 59.6M | 67.9M | 62.7M | 64.2M | 63.8M | 56.4M | 54.9M | 65.5M | 59.2M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 17.5M | n/a | 97.2M | 72.7M | n/a | n/a | n/a | n/a | n/a | n/a | 1.8M | 2M | 3.4M |
Short-Term Debt | 9.4M | 9.4M | 20.3M | 9.4M | 24.6M | 9.4M | 21.4M | 18.9M | 19.7M | 18.3M | 6.2M | 19.6M | 18.2M | 14.5M | n/a | 14.7M | 14.9M | 15.1M |
Other Current Liabilities | n/a | n/a | 73.3M | 99.6M | 92M | 89M | 112.6M | -10.2M | -10.8M | 46.7M | 65.1M | 33.2M | 26M | 34.1M | n/a | 19.3M | 36.8M | 40.5M |
Total Current Liabilities | 134.6M | 137.2M | 165.9M | 212.9M | 208.2M | 205.2M | 234.6M | 170.7M | 160.5M | 158.5M | 185.8M | 162.3M | 151.1M | 152.9M | 139.2M | 129.2M | 158.3M | 154.6M |
Long-Term Debt | 95.7M | 98M | 125.3M | 152.6M | 164.9M | 167.2M | 159.4M | 258.3M | 203.3M | 204.7M | 226.3M | 247.8M | 249.3M | 254.4M | 130M | 145M | 165M | 175M |
Other Long-Term Liabilities | 4.3M | 4.5M | 4.4M | 10.6M | 10.5M | 10.8M | 10M | 15.6M | 15.4M | 15.5M | 23.5M | 27.8M | 27.7M | 28M | 9.1M | 10.1M | 10.6M | 10.9M |
Total Long-Term Liabilities | 128.1M | 131.2M | 159.8M | 213.6M | 227.6M | 228.2M | 221.5M | 332.1M | 271.4M | 277.7M | 309.9M | 349.4M | 350.1M | 357.1M | 191.5M | 206.8M | 228.7M | 241.6M |
Total Liabilities | 262.7M | 268.4M | 325.7M | 426.5M | 435.8M | 433.4M | 456.1M | 502.8M | 431.9M | 436.2M | 495.7M | 511.7M | 501.2M | 510M | 330.7M | 336M | 387M | 396.2M |
Total Debt | 137.3M | 140.9M | 170.2M | 202.2M | 218.3M | 214.7M | 209.1M | 306.7M | 253.9M | 255.4M | 280M | 304.2M | 305.9M | 308.9M | 187.5M | 205.8M | 227.4M | 240.2M |
Common Stock | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K | 500K |
Retained Earnings | -777.2M | -700.4M | -707M | -309.7M | -314M | -315.8M | -314.9M | -325.4M | -321.7M | -253.1M | -253.1M | -270M | -293.1M | -304.5M | -310.3M | -320.3M | -285.2M | -323.1M |
Comprehensive Income | -32M | -42.3M | -44.6M | -36.9M | -37.5M | -29.5M | -27M | -33M | -28.4M | -35.8M | -35.8M | -42.9M | -37.8M | -32.1M | -33.8M | -33.6M | -30M | -32.3M |
Shareholders Equity | 776.3M | 839.4M | 828.5M | 1.23B | 1.22B | 1.23B | 1.24B | 1.22B | 1.23B | 1.3B | 1.29B | 1.26B | 1.25B | 1.26B | 1.26B | 1.26B | 1.3B | 1.25B |
Total Investments | n/a | n/a | n/a | n/a | -1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |